ML
Mark Vander Lugt
Physician · University of Michigan Health-Ann Arbor
Credentials: · · · · ·
History
- 2019–Present
- 2009–2010
Pediatric Hematology-Oncology
- 2006–2009
Pediatrics
- 2002–2006
Research
ST2 as a marker for risk of therapy-resistant graft-versus-host disease and death
New England Journal of Medicine · 2013 · First of 18 authors · 342 citations
Regenerating islet-derived 3-alpha is a biomarker of gastrointestinal graft-versus-host disease
Blood · 2011 · 285 citations
SCID genotype and 6-month posttransplant CD4 count predict survival and immune recovery
Blood · 2018 · 146 citations
15 papers
15 papers
14 papers
14 papers · 5 as a fellow
14 papers
- LG
14 papers
Luigi Notarangelo
14 papers
14 papers
